Equities
Health CareHealth Care Equipment & Services
  • Price (GBX)671.50
  • Today's Change-13.50 / -1.97%
  • Shares traded1.38m
  • 1 Year change-27.41%
  • Beta1.0379
Data delayed at least 20 minutes, as of Sep 21 2017 17:09 BST.
More ▼

Key statistics

On Thursday, Mediclinic International PLC (MDC:LSE) closed at 671.50, 0.75% above its 52-week low of 666.50, set on Apr 06, 2017.
52-week range
Today
666.50Apr 06 2017961.00Sep 26 2016
Markit short selling activity
Low
Med
High
Open686.50
High686.50
Low670.50
Bid665.00
Offer845.00
Previous close685.00
Average volume1.40m
Shares outstanding737.24m
Free float371.94m
P/E (TTM)22.05
Market cap5.05bn GBP
EPS (TTM)0.3106
GBP
Annual div (ADY)7.90
GBX
Annual div yield (ADY)1.15%
Div ex-dateJun 22 2017
Div pay-dateJul 31 2017
Data delayed at least 20 minutes, as of Sep 21 2017 17:09 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Mediclinic International PLC shares was Hold at 829.00 on 25 May 2017Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.